D228
D228 is an orally active anti-inflammatory small molecule derived from Chimonanthus salicifolius. It suppresses lymphocyte activity, modulates the MyD88/TRAF6/p38 pathway, and elevates IL-10, demonstrating therapeutic potential for inflammatory bowel disease (IBD) in research models.
Product Specifications
CAS Number
2676188-98-8
Product Name Alternative
D 228
Field of Research
Immunology & Inflammation, Signal Transduction
Purity
99.91% (May vary between batches)
Solubility
DMSO:40 mg/mL (82.57 mM)
Smiles
O ([C@H]1[C@H] (OC (C) =O) [C@@H] (OC (C) =O) [C@H] (OC (C) =O) [C@@H] (COC (C) =O) O1) C=2C (=O) C (=C (C) C) OC2C
Molecular Formula
C22H28O12
Molecular Weight
484.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15123069 1 Vial
Lentiviral human SIGLEC12 shRNA (UAS) - Lentiviral human SIGLEC12 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details ELI-53113h 96 Tests
Human SYDE2(Rho GTPase-activating protein SYDE2)ELISA Kit
Sign In for Pricing
View Details